Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERTUGLIFLOZIN PIDOLATE vs ESCITALOPRAM OXALATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERTUGLIFLOZIN PIDOLATE vs ESCITALOPRAM OXALATE: Safety Overview

Metric ERTUGLIFLOZIN PIDOLATE ESCITALOPRAM OXALATE
Total FAERS Reports 681 30,355
Deaths Reported 4 3,531
Death Rate 0.6% 11.6%
Hospitalizations 128 11,942
Average Patient Age 57.0 yrs 50.0 yrs
% Female Patients 56.1% 61.8%
FDA Approval Date N/A Apr 2, 2012
Manufacturer Merck Sharp & Dohme LLC Quality Care Products, LLC
Route ORAL ORAL
Marketing Status N/A Prescription